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Summary
Immune responses differ between laboratory mice and humans. Chronic infection with viruses and 
parasites are common in humans, but are absent in laboratory mice, and thus represent potential 
contributors to inter-species differences in immunity. To test this, we sequentially infected 
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laboratory mice with herpesviruses, influenza, and an intestinal helminth, and compared their 
blood immune signatures to mock-infected mice before and after vaccination against Yellow Fever 
Virus (YFV-17D). Sequential infection altered pre- and post-vaccination gene expression, 
cytokines, and antibodies in blood. Sequential pathogen exposure induced gene signatures that 
recapitulated those seen in blood from pet store-raised versus laboratory mice, and adult versus 
cord blood in humans. Therefore basal and vaccine-induced murine immune responses are altered 
by infection with agents common outside of barrier facilities. This raises the possibility that we 
can improve mouse models of vaccination and immunity by selective microbial exposure of 
laboratory animals to mimic that of humans.
Introduction
Substantial variation in human immune responses is due to environmental influences 
(Brodin et al., 2015; Roederer et al., 2015). Potential variables include nutritional status, 
different health practices, age, socioeconomic status and geographic location. In addition, 
the bacterial microbiome influences immune and inflammatory responses (Honda and 
Littman, 2012; Hooper et al., 2012). An added, but less well understood, environmental 
contributor to variation is the history of infection with acute and chronic pathogens, 
including herpesviruses and intestinal parasites (Foxman and Iwasaki, 2011; Furman et al., 
2015; Salgame et al., 2013; Virgin, 2014; Virgin et al., 2009). Persistent infections change 
the immune response to unrelated pathogens and vaccines (Furman et al., 2015; Oldstone, 
2005; Osborne et al., 2014; Reese et al., 2014; Salgame et al., 2013; Selin et al., 2006; Slifka 
et al., 2003; Virgin, 2014). Some chronic co-infections enhance, while others inhibit 
immunity to secondary challenge (Barton et al., 2007; MacDuff et al., 2015; Stelekati et al., 
2014; Stelekati and Wherry, 2012). Moreover, humans are frequently infected with acute 
viral pathogens which may change the immune system (Foxman and Iwasaki, 2011).
There is concern that rodent models do not faithfully predict human immune responses 
(Mestas and Hughes, 2004; Seok et al., 2013; Takao and Miyakawa, 2015), limiting the 
value of this powerful model system. However, mouse models are indispensable for 
biomedical studies and play a significant role in the development of vaccines and 
therapeutics. This highlights the need for studies that identify environmental variables that 
might, in addition to chromosomal genetic variation, contribute to species-specific immune 
response differences between mice and humans. Notably, barrier-raised mice are free of 
many acute and chronic infections that are recognized to contribute to human immune 
variation (Salgame et al., 2013; Virgin, 2014). For example, people chronically infected with 
intestinal helminths have lower responses to vaccination with Bacillus Calmette-Guerin 
(BCG)(Elias et al., 2001), cholera (Cooper et al., 2001) and tetanus toxoid (Nookala et al., 
2004; Sabin et al., 1996). Furthermore, chronic infection with the herpesvirus 
cytomegalovirus (HCMV) alters responses to human influenza vaccination (Furman et al., 
2015), and infection of mice with murine CMV (MCMV) and/or a murine γ-herpesvirus 
(MHV68) alters bacterial immunity and reverses inherited immunodeficiency (Barton et al., 
2007; MacDuff et al., 2015). We therefore sought to test the hypothesis that infection 
history, and in particular the presence of chronic co-infections in mice with agents similar to 
those commonly acquired by human children as they develop, alters basal and vaccine-
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induced immunity. We went on to assess the relationship of the changes we observed to gene 
expression differences between cord blood and adult blood in humans.
Results
Reduced antibody response in mice co-infected with multiple viruses and a helminth after 
YFV-17D vaccination
We separated 159 C57Bl/6 barrier-raised mice into four separate experiments (Figure S1B). 
Within each experiment half of the mice were sequentially inoculated with PBS (‘mock-
infected’) and half were infected with a series of viruses and a helminth parasite starting at 
weaning to mimic a diverse infection history (‘co-infected’, Figure 1A, Figure S1). For co-
infections we chose MHV68 (related to human Epstein-Barr virus and Kaposi's sarcoma 
herpesvirus) and MCMV (related to human CMV), both of which establish persistent and 
latent infections in mice and alter immune responses and/or gene expression in multiple 
organs during chronic infection (Barton et al., 2007; Canny et al., 2014; White et al., 2010). 
Co-infected mice were also challenged with influenza strain WSN as a representative acute 
respiratory viral challenge, and Heligmosomoides polygyrus, an intestinal helminth that 
establishes chronic infection in the small intestines of mice (Osborne et al., 2014; Reese et 
al., 2014). All of these pathogens are models for pathogens that commonly infect humans 
starting early in childhood. Five to 16 weeks after the last infection, co-infected and mock-
infected mice were vaccinated with the live attenuated yellow fever vaccine YFV-17D. Total 
anti-YFV IgG was measured in serum following vaccination (Figure 1B). Co-infected and 
control mice exhibited equivalent antibody responses early after vaccination, but by day 34 
total anti-YFV IgG was lower in co-infected than mock mice (Figure 1B). Total neutralizing 
antibody titers were similar at this time point, suggesting that co-infection changed the 
amount of antibody rather than the quality of the neutralizing response (Figure 1C). Viral 
replication of YFV-17D is very low in mice and is often undetectable in vaccinated mice 
(Meier et al., 2009). Using a sensitive RT-PCR assay (Mantel et al., 2008) we detected no 
difference in the number of mice with detectable YFV in the draining lymph node either 3 or 
7 days after vaccination (Figure 1D), suggesting that antibody differences were not due to 
difference in virus replication. Whether the statistically significant difference we observe in 
total antibody to YFV-17D is biologically significant remains to be determined. Neutralizing 
antibody is used as a correlate of protection for YFV (Mason et al., 1973), however 
antibodies have other functions in controlling viruses and there is evidence these Fc-
mediated functions not measured by neutralization may have important roles in virus control 
(Chung et al., 2015; Pulendran and Ahmed, 2011).
Defining transcriptional effects of co-infections before and after vaccination
To define genome-wide transcriptional effects of co-infection on basal and vaccine-induced 
immunity, we harvested peripheral blood from mice prior to (day 0) and 3, 7, or 21 days 
after vaccination, and examined gene expression by microarray. Unsupervised analysis 
revealed significant differences between mock and co-infected samples, with mock samples 
clustering together and co-infected samples clustering separately (Figure S2). These data 
indicate that co-infection altered the basal state of the immune system prior to vaccination as 
well as gene expression patterns in blood cells following vaccination. Consistent with this, 
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fold change scatter plots indicated minimal overlap in gene expression profiles between co-
infected mice and mock-infected mice after vaccination at days 3 (rho =0.029), 7 (rho 
=0.11), and 21 (rho=0.06) (Figure S3). We identified genes differentially expressed between 
co-infected and mock mice, and performed K-means clustering to associate groups of genes 
that changed significantly over time during YFV infection between mock and co-infected 
mice. We identified five temporally distinct groups of genes differentially expressed between 
mock and co-infected mice. These genes contained a total of 701 genes that fall into a broad 
range of biological functions related to immunity, organelle function, protein catabolism, 
cell death, metabolism, hemostasis and other processes (Figure 2A, B).
Pathway analysis of five gene clusters in mock and co-infected mice
Cluster 1 and 2 contain genes that were relatively similar in expression in co-infected and 
mock mice prior to vaccination and were more increased in response to vaccination in mock 
than in co-infected mice, especially 7 and 21 days after vaccination (Figure 2A, B). Pathway 
analysis revealed that cluster 1 genes are involved in ubiquitination, cell cycle, NFκB 
signaling and innate immune response signaling (Figure 2C, Table S1). Cluster 2 includes a 
smaller set of genes with a similar kinetic pattern that are related to Golgi vesicle transport. 
Thus co-infection can substantially blunt transcriptional responses corresponding to these 
processes in barrier-raised mice.
Cluster 3 and 4 genes were elevated in co-infected mice prior to vaccination and were 
further induced by vaccination of co-infected mice at day 3 and then diminished with 
varying kinetics by days 7 and 21 (Figure 2A, B). These genes represent a set of processes 
that are induced by co-infection, but less substantially up-regulated by vaccination of mock 
mice. This suggests that co-infection markedly changed the basal state of the immune 
system and enhanced certain vaccine-induced transcriptional changes. Cluster 3 genes are 
involved in the response to interferon-γ (IFNγ) and IFNαβ, regulation of interleukin-1β 
(IL-1β) production, T cell activation, and cell death (Figure 2C, Table S1). These pathways 
are consistent with analysis of serum cytokine data, where elevated IFNγ and to a lesser 
extent IL-12p70 and IL-1β were detected in co-infected mice at day 0 prior to vaccination 
(Figure 2D). Cluster 4 genes are involved in amine metabolism, symbiotic interactions, and 
negative regulation of protein modifications (Figure 2C, Table S1).
Cluster 5 genes were lower prior to vaccination in co-infected mice and followed a kinetic 
pattern most similar to cluster 1 genes with the exception that these genes were induced by 
vaccination in mock mice earlier than observed for cluster 1 genes, peaking at day 3. These 
genes are involved in IL-12 production and the function of nonlymphoid blood cells such as 
basophils and phagocytes as well as platelets (Figure 2C, Table S1).
Leading Edge Metagene analysis and comparison of metagenes with pet store versus 
laboratory mice
Together these data indicate that a history of infection in barrier-raised mice with agents 
similar to those that commonly infect humans changes both the basal state of the immune 
system and the nature and the kinetics of vaccine responses. We next sought to determine 
how the sets of genes regulated by co-infection related to gene expression patterns observed 
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in other biologically relevant settings. We first considered that co-infection of barrier-raised 
laboratory mice might induce gene expression patterns similar to those observed in mice 
raised in non-barrier conditions. To this end, we performed Leading Edge Metagene (LEM) 
analysis (Godec et al., 2016), comparing co-infected and mock at baseline, to identify sets of 
genes with correlated expression (metagenes) representing specific biological processes 
within the co-infection gene expression profile in our data sets. This analysis identified a 
type I interferon response-enriched metagene in co-infected mice and a naïve lymphocyte-
enriched metagene in mock infected mice (Figure S4, Table S2). The significant enrichment 
of genes in co-infected mice in multiple pathways related to interferon signaling and innate 
immune responses is consistent with prior observations of the effects of latent and persistent 
herpesvirus infection on IFNγ expression (Barton et al., 2007; MacDuff et al., 2015).
We next performed enrichment analysis of the co-infected day 0 versus mock day 0 type I 
interferon response metagene with gene expression observed in pet store mice compared to 
barrier-raised laboratory mice. In addition, we compared these metagenes to laboratory mice 
co-housed with pet store mice compared to barrier-raised laboratory mice (Beura et. al, in 
submission) (Figure 3A, B). The type I interferon metagene found in co-infected mice was 
significantly enriched in pet store mice as well as laboratory mice co-housed with pet store 
mice, while the naïve lymphocyte metagene found in mock mice was significantly enriched 
in laboratory mice (Figure 3). Thus co-infected mice express genes found in mice raised in a 
more “dirty” environment compared to a specific pathogen-free barrier.
Comparison of metagenes in mock and co-infected mice with neonate and adult blood 
gene expression signatures
To understand whether these observations relate to species-specific gene expression patterns 
differing between barrier-raised mice and adult humans, we compared gene expression 
profiles prior to vaccination in mock and co-infected mice with human cord blood and adult 
blood (Votavova et al., 2011). We found that the type-I interferon metagene identified in co-
infected mice was significantly enriched in maternal human blood while the naïve 
lymphocyte metagene in mock mice was significantly enriched in human cord blood (Figure 
4). Taken together, these data suggest that mock mice from a barrier facility have a naïve or 
immature immune system that is more similar to human neonates than human adults. Co-
infection of these barrier-raised mice promotes an immune system gene expression pattern 
more similar to pet store-raised mice and adult humans.
Discussion
These data indicate that studies of immune responses in mice should consider the virome, 
helminth infection, and, more broadly, infection history as potential determinants of species-
specific immune responses. Chromosomal genes that differ between mice and humans do 
not solely determine inter-species differences in the immune system. Environmental factors 
that contribute to variation in immune response include nutritional status, age, 
socioeconomic status, geographic location, and the microbiome. While studies of the 
bacterial microbiome highlight the important contribution this variable makes to 
inflammatory responses (Honda and Littman, 2012; Hooper et al., 2012), there are fewer 
Reese et al. Page 5
Cell Host Microbe. Author manuscript; available in PMC 2017 May 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
studies addressing the contribution of acute and chronic viruses and parasites to varying 
immune responses. Recent work showed that an acute infection compromised tissue-specific 
immunity even after clearance of the bacteria (Fonseca et al., 2015). Our work identifies 
chronic pathogens as important contributors to differences in response to vaccines, and 
likely other inflammatory conditions.
Potential mechanisms for how co-infections alter immunity are complex. Possible 
mechanisms include chronic stimulation of innate immune responses that regulate adaptive 
immunity, antigenic mimicry, cross-reactive immune responses, altered antigen presentation 
and changes in differentiation of memory and naïve lymphocyte responses (Hensley et al., 
2007; Oldstone, 2005; Selin et al., 2006; Stelekati et al., 2014; Stelekati and Wherry, 2012; 
Virgin, 2014; Virgin et al., 2009). Latent infection with the γ-herpesvirus used in our studies, 
MHV68, alters the number and phenotype of memory CD8+ T cells (Barton et al., 2014). 
Latent MCMV infection also results in profound alteration in the T cell compartment, 
leading to impaired naïve T cell function (Cicin-Sain et al., 2012), despite no increase in 
susceptibility to secondary challenge with influenza virus, West Nile virus, or vesicular 
stomatitis (Marandu et al., 2015). Any or all of these mechanisms could be important 
contributors to co-infection associated changes in gene expression and altered antibody 
responses to YFV vaccination.
It is important to note that effects of co-infections and mechanisms that drive co-infection 
mediated changes in immune responses will likely differ depending on the co-infecting 
pathogens. Some pathogens will have more profound effects on T cells, for example, 
whereas others will have stronger effects on other aspects of immunity. Moreover, the effects 
driven by co-infections could be different for different vaccines. Some vaccine responses 
may be more affected by co-infections than others. More detailed studies will be required to 
determine which or what combination of our co-infecting pathogens are required for the 
effects we are seeing. Additionally, other studies examining different co-infecting pathogens 
and vaccines will be required to delineate mechanisms.
YFV vaccine is extremely efficacious, however immune responses in humans differ 
significantly. Evidence suggests that although vaccine provides protection in greater than 
80% of vaccinees, levels of neutralizing antibody and T cell responses are significantly 
different (Querec et al., 2009). Additionally, B and T cell responses to YFV vaccination are 
measurably different in people from different parts of the world with variable levels of 
baseline immune activation prior to vaccination (Gaucher et al., 2008; Muyanja et al., 2014). 
Together, these data suggest that environmental factors, including possible co-infections may 
contribute to inter-individual variation.
In order to enhance reproducibility of mouse studies the biomedical research community 
rendered this important research animal specific-pathogen free. In doing so, researchers may 
have created an immune response that is less relevant to studies of humans or other 
mammals raised outside of barrier containment. Careful consideration of these issues may 
enhance the value of mouse models for experimental research relevant to human disease. As 
mechanisms for effects such as the co-infection-dependent changes in immunity identified 
here are defined, we speculate that it may become possible to manipulate the nature of 
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mouse immune responses by reintroducing, under controlled circumstances, some of the 
natural infectious exposures that constitute the selective pressures that shaped the mouse 
immune system. This may partially humanize murine immune responses.
Experimental Procedures
Animals, infections, and sample collection
The individual experiments are outlined in Figure S1. In summary, at weaning mice were 
divided into two groups. The mock group was housed in the biohazard facility with the co-
infected group. The co-infected mice were infected with 105 plaque forming units (PFU) 
intranasally of MHV68, followed by 105 PFU (in PBS) tissue culture passage MCMV 
intraperitoneally, 103 PFU influenza strain WSN (in PBS) intranasally, and 50 L3 larvae of 
H. polygyrus orally. Mice were then rested in the biohazard facility for 5-12 weeks. Mock 
and co-infected mice were challenged with 106 PFU of YFV-17D subcutaneously in the 
footpad. Mice were sacrificed on days 0, 3, 7, 21, and for experiments 1, 2, and 4 on days 
34-40. Blood cells, serum, spleen, draining lymph node were collected. Blood cells were 
processed using RiboPure RNA purification kit from whole blood (Thermo Fisher 
Scientific). RNA from individual mice from each timepoint was pooled within an 
experiment for microarrays. Samples were hybridized to Affymetrix Mouse 430 2.0 arrays.
Analysis of microarray data
Prior to analysis, mouse microarray data were processed and normalized using the 
Affymetrix MAS5 algorithm and batch correction was performed using the ComBat 
algorithm. Genes exhibiting differential kinetics between co-infected and mock samples over 
the d0 to d21 time course were identified using maSigPro (Conesa et al., 2006) (default FDR 
<0.05). Gene set enrichment analysis (GSEA) was performed as described previously 
(Subramanian et al., 2005). LEM analysis was performed downstream of GSEA to yield 
groups of genes, termed metagenes, which are coordinately up-regulated in a given 
phenotypic comparison and common to multiple enriched gene sets. Metagenes were 
identified for d0 co-infected relative to d0 mock and vice versa. Enrichments of co-infected 
and mock metagenes in pet store vs. laboratory mouse (GSE78979), cohoused vs. laboratory 
mouse (GSE78979), and adult PBMC vs. cord PBMC array data (GSE27272) (Votavova et 
al., 2011) were determined using standard GSEA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Co-infection of mice with chronic viruses and a helminth leads to reduced antibody 
production after vaccination with YFV-17D
(A) Experimental outline. See experimental procedures and Figure S1 for more detail on 
number of mice and groups.
(B) Measurement of total anti-YFV-17D IgG from serum.
(C) Total serum neutralizing anti-YFV-17D antibody was quantified 34-40 days after 
vaccination.
(D) Genome copies (normalized to actin) of YFV-17D were measured in draining lymph 
node (LN) of mice on days 3 and 7 following vaccination. Numbers above bar are the 
number of mice positive for YFV genome over the number of mice analyzed. One-way 
ANOVA was used to calculate statistical differences *** p< 0.01. Dots represent individual 
animals, and bars represent averages +/− SEM.
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Figure 2. Microarray analysis of blood samples of vaccinated animals reveals kinetically distinct 
gene expression in co-infected mice relative to mock
(A) Heatmap of significant kinetically different genes between mock and co-infected. See 
Table S1.
(B) Kinetics of each cluster, represented in individual points for each of three experiments as 
the median expression value of all genes in a given cluster across a sample. Line represents 
the mean of three replicates median expression values.
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(C) Heatmap of top significantly enriched GO terms in each cluster. Lack of ontological 
agreement between mock and co-infected high clusters suggests highly differential response 
to vaccine.
(D) Analysis of cytokines in serum of vaccinated animals over time in pictograms (pg)/ml. 
One-way ANOVA was used to calculate statistical differences * p< 0.5, ** p<0.1, *** 
p<0.01. Symbols are individual animals, and bars are averages of all animals +/− SEM.
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Figure 3. Comparison of metagenes from co-infected and mock mice with pet store-raised and 
laboratory-raised mice indicates overlap of co-infected mice with pet store mice and mock mice 
with laboratory-raised mice
(A) Enrichment analysis of a co-infected d0 vs. mock d0 metagene (type-I interferon 
response) and mock vs. co-infected d0 metagene (naive lymphocyte) in pet store vs. 
laboratory mice
(B) Enrichment analysis of a co-infected d0 vs. mock d0 metagene (type-I interferon 
response) and mock vs. co-infected d0 metagene (naive lymphocyte) in cohoused vs. 
laboratory array data.
See Figure S4 and Table S2.
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Figure 4. Co-infected mice have parallel gene expression with human maternal blood, whereas 
mock mice have parallel gene expression with human cord blood
Enrichment analysis of co-infected d0 vs. mock d0 metagene (type-I interferon response) 
and mock vs. co-infected d0 metagene (naive lymphocyte) in human maternal and cord 
blood array data.
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